VP

Vandana Parikh

Active Director Director DIN 08733851
DIN 08733851 First appointment Mar 2020 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Vandana Parikh

Data last updated:

Vandana Parikh is a Director at Ai Di Pharmaceuticals Private Limited (since 2020). The company operates in FMCG. Ai Di Pharmaceuticals Private Limited reported revenue of ₹14.5 Lakh (FY 2024).

DIN 08733851
Primary Designation Director
Industry FMCG
First Appointment 11 Mar 2020
Oldest Company Age 11 yrs
Largest company Ai Di Pharmaceuticals Private Limited · ₹14.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Mar 20202015₹14.5 Lakh (FY 2024)Active

Board colleagues of Vandana Parikh

NameDINCompanyDesignation
Kirit Parikh07132294Ai Di Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ai Di Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vandana Parikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vandana Parikh

Vandana Parikh currently holds 1 directorship: Ai Di Pharmaceuticals Private Limited (Director, since 11 Mar 2020, revenue ₹14.5 Lakh (FY 2024)).

Vandana Parikh was first appointed on 11 Mar 2020 as Director at Ai Di Pharmaceuticals Private Limited.

The current boards of Vandana Parikh's companies include Kirit Parikh (Ai Di Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available